Takeda Pharmaceutical Company LimitedTT

Takeda Pharmaceutical Company Limited

15.09USDR
−0.08−0.53%
As of today at 16:52 GMT
USD
No trades
See on Supercharts
Next report date
May 8
Report period
Q4 2024
EPS estimate
−0.17 USD
Revenue estimate
‪6.94 B‬ USD
Market capitalization
‪47.93 B‬USD
0.43USD
‪996.30 M‬USD
‪29.49 B‬USD
‪3.17 B‬
Beta (1Y)
−0.03

About TAKEDA PHARMACEUTICAL CO LTD


CEO
Christophe Weber
Website
Headquarters
Osaka
Founded
1781
FIGI
BBG000LF8708
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Performance
‪−3.5%‬
‪0.0%‬
‪3.5%‬
‪7.0%‬
‪10.5%‬
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−3.00 B‬‬
‪0.00‬
‪‪3.00 B‬‬
‪‪6.00 B‬‬
‪‪9.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬
Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪10.00 B‬‬
‪‪20.00 B‬‬
‪‪30.00 B‬‬
‪‪40.00 B‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:May 8, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪−0.22‬
‪−0.11‬
‪0.00‬
‪0.11‬
‪0.22‬
Actual
Estimate

No news here

Looks like there's nothing to report right now

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
TKPH5010047
Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050
Yield to maturity
6.84%
Maturity date
Jul 9, 2050
TKPH5010048
Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060
Yield to maturity
6.62%
Maturity date
Jul 9, 2060
TKPH5010046
Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040
Yield to maturity
6.27%
Maturity date
Jul 9, 2040
TKPH5841810
Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064
Yield to maturity
5.84%
Maturity date
Jul 5, 2064
TKPH5841809
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054
Yield to maturity
5.78%
Maturity date
Jul 5, 2054
B
TKPH4369980
Baxalta Incorporated 5.25% 23-JUN-2045
Yield to maturity
5.62%
Maturity date
Jun 23, 2045
TKPH5841808
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044
Yield to maturity
5.62%
Maturity date
Jul 5, 2044
TKPH5841807
Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034
Yield to maturity
5.17%
Maturity date
Jul 5, 2034
TKPH5010045
Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030
Yield to maturity
5.08%
Maturity date
Mar 31, 2030
B
TKPH4370840
Baxalta Incorporated 4.0% 23-JUN-2025
Yield to maturity
4.85%
Maturity date
Jun 23, 2025
TKDB
TAKEDA PHARMA. 20/40
Yield to maturity
4.65%
Maturity date
Jul 9, 2040

See all TAK bonds